SCYNEXIS

SCYNEXIS Quick Ratio

The Quick Ratio (Acid Test) of SCYNEXIS (SCYX) as of Oct 19, 2026 is 7.34. In the previous year, Quick Ratio (Acid Test) was 2.32 — a change of 216.09% (higher).

Quick Ratio

7.34

YoY

216.09%

Last updated:

Quick Ratio (Acid Test) of SCYNEXIS is 2025 7.34 . Quick Ratio (Acid Test) of SCYNEXIS was 2024 2.32 . It decreases by 216.09% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

Quick Ratio (Acid Test) of SCYNEXIS is 7.34 in 2025.

Quick Ratio (Acid Test) of SCYNEXIS changed from 2.32 to 7.34, representing a 216.09% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) SCYNEXIS since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s SCYNEXIS with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — SCYNEXIS

All Key Metrics — SCYNEXIS